Challenges in operationalising clinical trials in India during the COVID-19 pandemic

Affiliations

• ¹ The George Institute for Global Health, New Delhi, India.
• ² The George Institute for Global Health, New Delhi, India; Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
• ³ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.
• ⁴ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
• ⁵ The George Institute for Global Health, New Delhi, India; Department of Critical Care Medicine, Apollo Hospitals, Chennai, India. Electronic address: bharath@icuconsultants.com.
• ⁶ Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Department of Critical Care, Wesley Hospital, Brisbane, QLD, Australia; Department of Critical Care, University of Queensland, Brisbane, QLD, Australia.
• ⁷ The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College London, London, UK; Manipal Academy of Higher Education, Manipal, India.